Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xarelto
Pharma
Bayer weathers LOE for Xarelto with success of Kerendia, Nubeqa
Thanks to hefty sales increases from Kerendia and Nubeqa, Bayer’s pharma division weathered the loss of exclusivity in the U.S. of Xarelto in Q1.
Kevin Dunleavy
May 13, 2025 11:25am
Bayer projects Xarelto's sales decline will gain steam in 2025
Mar 5, 2025 11:17am
JPM25: Bayer gears up for 'must-win battles' amid Xarelto decline
Jan 15, 2025 8:00pm
Bayer's 'transition year' looms as Xarelto sales falter
Nov 12, 2024 3:03pm
J&J ushers in new 340B rebate policy for Stelara, Xarelto
Aug 26, 2024 11:23am
Bayer charts growth course amid Xarelto's ongoing sales descent
Aug 6, 2024 12:29pm
